Literature DB >> 3106710

Pompe's disease in Chinese and prenatal diagnosis by determination of alpha-glucosidase activity.

C Y Lin, B Hwang, K J Hsiao, Y R Jin.   

Abstract

We measured the activities of two major forms of alpha-glucosidase in lymphocytes and cultured fibroblasts from normal healthy controls and patients with Pompe's disease by using 4-methylumbelliferyl-alpha-D-glucoside as substrate. We found (1) enzyme activity of the pH 4 and pH 6 forms varied with age, and (2) patients with Pompe's disease showed very low activity of the pH 4 form and a low ratio of pH 4 to pH 6 forms. We established a reference range and were also able to diagnose prenatally the homozygote and heterozygote forms of Pompe's disease which occurred in families of southern Chinese and aborigines in Taiwan. This enzyme biochemical study may be useful in anthropology.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106710     DOI: 10.1007/bf01799482

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  10 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  The change in the pH 4 and pH 6 forms of alpha-glucosidase in cultured amniotic fluid cells and its implication in prenatal diagnosis of Pompe's disease.

Authors:  A Fujimoto; A L Fluharty
Journal:  Clin Chim Acta       Date:  1978-12-01       Impact factor: 3.786

3.  Late-onset acid maltase deficiency. Detection of patients and heterozygotes by urinary enzyme assay.

Authors:  M Mehler; S DiMauro
Journal:  Arch Neurol       Date:  1976-10

4.  Alpha-1,4 glucosidase activity in Pompe's disease.

Authors:  I S Salafsky; H L Nadler
Journal:  J Pediatr       Date:  1971-11       Impact factor: 4.406

5.  The use of leucocytes as an aid in the diagnosis of glycogen storage disease type II (Pompe's disease).

Authors:  J F Koster; R G Slee; W C Hülsmann
Journal:  Clin Chim Acta       Date:  1974-03-26       Impact factor: 3.786

6.  Lysosomal alpha-glucosidase in type II glycogenosis; activity in leukocytes and cell cultures in relation to genotype.

Authors:  H M Nitowsky; A Grunfeld
Journal:  J Lab Clin Med       Date:  1967-03

7.  Biochemical, immunological, and cell genetic studies in glycogenosis type II.

Authors:  A J Reuser; J F Koster; A Hoogeveen; H Galjaard
Journal:  Am J Hum Genet       Date:  1978-03       Impact factor: 11.025

8.  Identification of heterozygotes for glycogenosis 2 (acid maltase deficiency).

Authors:  M C Loonen; A W Schram; J F Koster; M F Niermeijer; H F Busch; J J Martin; B Brouwer-Kelder; W Mekes; R G Slee; J M Tager
Journal:  Clin Genet       Date:  1981-01       Impact factor: 4.438

9.  Prenatal diagnosis of type II glycogenosis (Pompe's disease) using microchemical analyses.

Authors:  M F Niermeijer; J F Koster; M Jahodova; J Fernandes; M J Heukels-Dully; H Galjaard
Journal:  Pediatr Res       Date:  1975-05       Impact factor: 3.756

10.  Comparative study of acid maltase deficiency. Biochemical differences between infantile, childhood, and adult types.

Authors:  C Angelini; A G Engel
Journal:  Arch Neurol       Date:  1972-04
  10 in total
  11 in total

1.  Point mutation in Pompe disease in Chinese.

Authors:  J J Shieh; L Y Wang; C Y Lin
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

Review 2.  Muscle glycogenosis.

Authors:  S W Moses
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Identification of eight novel mutations of the acid alpha-glucosidase gene causing the infantile or juvenile form of glycogen storage disease type II.

Authors:  L Wan; C-C Lee; C-M Hsu; W-L Hwu; C-C Yang; C-H Tsai; F-J Tsai
Journal:  J Neurol       Date:  2008-05-06       Impact factor: 4.849

4.  Zinc can activate cellular acidic alpha-D-glucosidase activity.

Authors:  C Y Lin; B T Hwang
Journal:  Biochem Genet       Date:  1988-06       Impact factor: 1.890

5.  Lower Urinary Tract Symptoms and Incontinence in Children with Pompe Disease.

Authors:  Divya Ajay; Erin R McNamara; Stephanie Austin; John S Wiener; Priya Kishnani
Journal:  JIMD Rep       Date:  2015-11-05

6.  Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy.

Authors:  Chien-Yu Hsueh; Chii-Yuan Huang; Chia-Feng Yang; Chia-Chen Chang; Wei-Sheng Lin; Hsiu-Lien Cheng; Shang-Liang Wu; Yen-Fu Cheng; Dau-Ming Niu
Journal:  Orphanet J Rare Dis       Date:  2021-08-05       Impact factor: 4.123

Review 7.  The humanistic burden of Pompe disease: are there still unmet needs? A systematic review.

Authors:  Benedikt Schoser; Deborah A Bilder; David Dimmock; Digant Gupta; Emma S James; Suyash Prasad
Journal:  BMC Neurol       Date:  2017-11-22       Impact factor: 2.474

8.  Clinical Analysis of Algerian Patients with Pompe Disease.

Authors:  Y Sifi; M Medjroubi; R Froissart; N Taghane; K Sifi; A Benhabiles; S Lemai; S Semra; H Benmekhebi; Z Bouderda; N Abadi; A Hamri
Journal:  J Neurodegener Dis       Date:  2017-02-06

Review 9.  A Systematic Review of the Health Economics of Pompe Disease.

Authors:  Benedikt Schoser; Andreas Hahn; Emma James; Digant Gupta; Matthew Gitlin; Suyash Prasad
Journal:  Pharmacoecon Open       Date:  2019-12

10.  Carrier frequency and predicted genetic prevalence of Pompe disease based on a general population database.

Authors:  Kyung Sun Park
Journal:  Mol Genet Metab Rep       Date:  2021-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.